[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100516213":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":11,"centralContacts":36,"locations":45,"responsibleParty":58,"collaborators":11,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":11,"eligibilityCriteria":66,"healthyVolunteers":62,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":11,"studyType":73,"phases":74,"briefSummary":77,"conditions":78,"keywords":80,"overallStatus":47,"whyStopped":11,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Seoul National University Hospital","OTHER",[8,15,19],{"label":9,"type":10,"description":11,"interventionNames":12},"electircal stimulation + betahistine","EXPERIMENTAL",null,[13,14],"Device: YPS-201b","Drug: betahistine",{"label":16,"type":17,"description":11,"interventionNames":18},"sham electircal stimulation + betahistine","SHAM_COMPARATOR",[14,13],{"label":20,"type":6,"description":21,"interventionNames":22},"betahistine","control group",[14],[24,29,33],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"DEVICE","YPS-201b","electrical stimulation device.",[9],{"type":30,"name":20,"description":31,"armGroupLabels":32,"otherNames":11},"DRUG","Relieve symptoms of balance disorders or dizziness",[20,9,16],{"type":25,"name":26,"description":34,"armGroupLabels":35,"otherNames":11},"sham electrical stimulation device.",[16],[37,42],{"name":38,"role":39,"phone":40,"phoneExt":11,"email":41},"Myung-Whan Suh","CONTACT","+821039490330","drmung@naver.com",{"name":43,"role":39,"phone":11,"phoneExt":11,"email":44},"Dong-min Kang","dongmin_4@naver.com",[46],{"facility":5,"status":47,"city":48,"state":11,"zip":11,"country":49,"countryCode":11,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"RECRUITING","Seoul","South Korea",{"type":51,"coordinates":52},"Point",[53,54],126.9784,37.566,{"lat":54,"lon":53},[57],{"name":38,"role":39,"phone":11,"phoneExt":11,"email":11},{"type":59,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100516213","phase-1-modulating-auditory-symptoms-and-vertigo-of-menieres-disease-by-non-invasive-mastoid-electric-stimulation-100516213",false,"NCT06001593","Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation","Pilot Study of Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation: Double-blind, Randomized, Sham-controlled, Investigator-initiated Trial","Inclusion Criteria:\n\n* Patients with dizziness (Meniere's) only, who understand the nature of the study and are willing to participate voluntarily.\n* The frequency of the hearing loss is between 250 kHz and 1 kHz.\n* Patients with bilateral 500, 1000, and 2000 Hz hearing threshold averages within 65 dB HL\n* Patients who have received conventional pharmacotherapy for other dizziness conditions with a washout period of 2 months.\n* To be eligible for subjects in the active phase of the disease, there must be at least 1 vertigo attack in the 6 months before study entry.\n* If tests for renal function, electrolytes, etc. are performed and no problems are found\n\nExclusion Criteria:\n\n* Patients with an otologic condition other than Meniere'ss (dizziness) (otitis media, profound hearing loss, hyperacusis, etc.).\n* Patients' conditions that may affect EEG measurements, such as a stroke, brain hemorrhage, or brain tumor.\n* Patients with kidney disease\n* Patients Have or have had a serious medical condition, such as cancer (including leukemia, blood cancers, epilepsy, and neuropsychiatric conditions).\n* Patients with an artificial implant in the body (cochlear implant, hip joint, pacemaker, etc.)\n* Women of childbearing potential, pregnant women, or nursing mothers\n* Patients who can have Injuries or dermatologic abnormalities at the site of application of the equipment.\n* Patients with coronary artery disease, uncontrolled high blood pressure, or other serious medical conditions (including kidney disease).","ALL","19 Years","80 Years",{"count":71,"type":72},120,"ESTIMATED","INTERVENTIONAL",[75,76],"PHASE1","PHASE2","This study is a Double-blind, Randomized, Sham-controlled, Investigator-initiated trial. To explore the effectiveness of non-invasive inner ear electrical stimulation of the mastoid behind the ear in controlling auditory symptoms and dizziness in patients with Meniere's disease.",[79],"Meniere's Disease",[81,82,83],"Electrical stimulation","Electroceutical","Meniere's disease","2024-12-02",{"date":86,"type":87},"2024-12-05","ACTUAL",{"date":89,"type":87},"2023-09-18",{"date":91,"type":72},"2025-12-31",{"name":5,"class":6},1]